| Sinusitis (acute): antimicrobial prescribing | NG79 | | |
| Cataracts in adults: management | NG77 | | |
| Cystic fibrosis: diagnosis and management | NG78 | | |
| Hepatitis B (chronic): diagnosis and management | CG165 | | |
| Child maltreatment: when to suspect maltreatment in under 18s | CG89 | | |
| Child abuse and neglect | NG76 | | |
| Faltering growth: recognition and management of faltering growth in children | NG75 | | |
| Intermediate care including reablement | NG74 | | |
| Type 2 diabetes: prevention in people at high risk | PH38 | | |
| Fertility problems: assessment and treatment | CG156 | | |
| Psoriasis: assessment and management | CG153 | | |
| Vitamin D: supplement use in specific population groups | PH56 | | |
| Advanced breast cancer: diagnosis and treatment | CG81 | | |
| Developmental follow-up of children and young people born preterm | NG72 | | |
| moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment | MTG2 | | |
| Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition | CG32 | | |
| Parkinson's disease in adults | NG71 | | |
| Constipation in children and young people: diagnosis and management | CG99 | | |
| New generation cardiac CT scanners (Aquilion ONE, Brilliance iCT, Discovery CT750 HD and Somatom Definition Flash) for cardiac imaging in people with suspected or known coronary artery disease in whom imaging is difficult with earlier generation CT scanners | DG3 | | |
| Air pollution: outdoor air quality and health | NG70 | | |
| Eliglustat for treating type 1 Gaucher disease | HST5 | | |
| Multiple frequency bioimpedance devices to guide fluid management in people with chronic kidney disease having dialysis | DG29 | | |
| Obesity: working with local communities | PH42 | | |
| Spondyloarthritis in over 16s: diagnosis and management | NG65 | | |
| Idiopathic pulmonary fibrosis in adults: diagnosis and management | CG163 | | |
| Virtual chromoendoscopy to assess colorectal polyps during colonoscopy | DG28 | | |
| Intravenous fluid therapy in adults in hospital | CG174 | | |
| Antisocial behaviour and conduct disorders in children and young people: recognition and management | CG158 | | |
| Alcohol-use disorders: diagnosis and management of physical complications | CG100 | | |
| Sexually transmitted infections: condom distribution schemes | NG68 | | |
| Irritable bowel syndrome in adults: diagnosis and management | CG61 | | |
| Managing medicines for adults receiving social care in the community | NG67 | | |
| Patient group directions | MPG2 | | |
| Mental health of adults in contact with the criminal justice system | NG66 | | |
| Molecular testing strategies for Lynch syndrome in people with colorectal cancer | DG27 | | |
| Migalastat for treating Fabry disease | HST4 | | |
| Drug misuse prevention: targeted interventions | NG64 | | |
| Healthcare-associated infections: prevention and control in primary and community care | CG139 | | |
| HumiGard for preventing inadvertent perioperative hypothermia | MTG31 | | |
| Osteoporosis: assessing the risk of fragility fracture | CG146 | | |
| Cerebral palsy in under 25s: assessment and management | NG62 | | |
| Antimicrobial stewardship: changing risk-related behaviours in the general population | NG63 | | |
| Organ donation for transplantation: improving donor identification and consent rates for deceased organ donation | CG135 | | |
| Hypothermia: prevention and management in adults having surgery | CG65 | | |
| XprESS multi sinus dilation system for treating chronic sinusitis | MTG30 | | |
| HIV testing: increasing uptake among people who may have undiagnosed HIV | NG60 | | |
| Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis | CG95 | | |
| Coexisting severe mental illness and substance misuse: community health and social care services | NG58 | | |
| Spasticity in under 19s: management | CG145 | | |
| High-throughput non-invasive prenatal testing for fetal RHD genotype | DG25 | | |
| Physical health of people in prison | NG57 | | |
| Psychosis and schizophrenia in children and young people: recognition and management | CG155 | | |
| Multimorbidity: clinical assessment and management | NG56 | | |
| Harmful sexual behaviour among children and young people | NG55 | | |
| Mental health problems in people with learning disabilities: prevention, assessment and management | NG54 | | |
| Transition between inpatient mental health settings and community or care home settings | NG53 | | |
| Stable angina: management | CG126 | | |
| Acute upper gastrointestinal bleeding in over 16s: management | CG141 | | |
| Palliative care for adults: strong opioids for pain relief | CG140 | | |
| Non-Hodgkin's lymphoma: diagnosis and management | NG52 | | |
| Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures | CG64 | | |
| Non-alcoholic fatty liver disease (NAFLD): assessment and management | NG49 | | |
| Oral health for adults in care homes | NG48 | | |
| Haematological cancers: improving outcomes | NG47 | | |
| ImmunoCAP ISAC 112 for multiplex allergen testing | DG24 | | |
| Controlled drugs: safe use and management | NG46 | | |
| Routine preoperative tests for elective surgery | NG45 | | |
| Workplace health: management practices | NG13 | | |
| Community engagement: improving health and wellbeing and reducing health inequalities | NG44 | | |
| Spectra Optia for automatic red blood cell exchange in people with sickle cell disease | MTG28 | | |
| Transition from children's to adults' services for young people using health or social care services | NG43 | | |
| Therapeutic monitoring of TNF-alpha inhibitors in Crohn's disease (LISA-TRACKER ELISA kits, IDKmonitor ELISA kits, and Promonitor ELISA kits) | DG22 | | |
| Fractures (non-complex): assessment and management | NG38 | | |
| Major trauma: assessment and initial management | NG39 | | |
| Major trauma: service delivery | NG40 | | |
| Spinal injury: assessment and initial management | NG41 | | |
| Skin cancer prevention | PH32 | | |
| Sunlight exposure: risks and benefits | NG34 | | |
| Older people: independence and mental wellbeing | NG32 | | |
| Care of dying adults in the last days of life | NG31 | | |
| Oral health promotion: general dental practice | NG30 | | |
| Transition between inpatient hospital settings and community or care home settings for adults with social care needs | NG27 | | |
| Children's attachment: attachment in children and young people who are adopted from care, in care or at high risk of going into care | NG26 | | |
| Blood transfusion | NG24 | | |
| VivaScope 1500 and 3000 imaging systems for detecting skin cancer lesions | DG19 | | |
| Older people with social care needs and multiple long-term conditions | NG22 | | |
| Developing and updating local formularies | MPG1 | | |
| Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset | NG16 | | |
| Procalcitonin testing for diagnosing and monitoring sepsis (ADVIA Centaur BRAHMS PCT assay, BRAHMS PCT Sensitive Kryptor assay, Elecsys BRAHMS PCT assay, LIAISON BRAHMS PCT assay and VIDAS BRAHMS PCT assay) | DG18 | | |
| Home care: delivering personal care and practical support to older people living in their own homes | NG21 | | |
| Coeliac disease: recognition, assessment and management | NG20 | | |
| Antimicrobial stewardship: systems and processes for effective antimicrobial medicine use | NG15 | | |
| Lower urinary tract symptoms in men: management | CG97 | | |
| Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challenges | NG11 | | |
| Violence and aggression: short-term management in mental health, health and community settings | NG10 | | |
| Obesity prevention | CG43 | | |
| Preventing excess weight gain | NG7 | | |
| Excess winter deaths and illness and the health risks associated with cold homes | NG6 | | |
| Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes | NG5 | | |
| VibraTip for testing vibration perception to detect diabetic peripheral neuropathy | MTG22 | | |
| Safe midwifery staffing for maternity settings | NG4 | | |
| Bladder cancer: diagnosis and management | NG2 | | |
| Eculizumab for treating atypical haemolytic uraemic syndrome | HST1 | | |
| Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment | DG16 | | |
| The ReCell Spray‑On Skin system for treating skin loss, scarring and depigmentation after burn injury | MTG21 | | |
| Maternal and child nutrition | PH11 | | |
| Gallstone disease: diagnosis and management | CG188 | | |
| Oral health: local authorities and partners | PH55 | | |
| Alcohol-use disorders: diagnosis, assessment and management of harmful drinking (high-risk drinking) and alcohol dependence | CG115 | | |
| Physical activity: exercise referral schemes | PH54 | | |
| Drug allergy: diagnosis and management | CG183 | | |
| Detecting, managing and monitoring haemostasis: viscoelastometric point‑of‑care testing (ROTEM, TEG and Sonoclot systems) | DG13 | | |
| Safe staffing for nursing in adult inpatient wards in acute hospitals | SG1 | | |
| The geko device for reducing the risk of venous thromboembolism | MTG19 | | |
| Weight management: lifestyle services for overweight or obese adults | PH53 | | |
| Pressure ulcers: prevention and management | CG179 | | |
| Measuring fractional exhaled nitric oxide concentration in asthma: NIOX MINO, NIOX VERO and NObreath | DG12 | | |
| Contraceptive services for under 25s | PH51 | | |
| Needle and syringe programmes | PH52 | | |
| Managing medicines in care homes | SC1 | | |
| Psychosis and schizophrenia in adults: prevention and management | CG178 | | |
| Domestic violence and abuse: multi-agency working | PH50 | | |
| Behaviour change: individual approaches | PH49 | | |
| Weight management: lifestyle services for overweight or obese children and young people | PH47 | | |
| Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel | DG11 | | |
| EGFR‑TK mutation testing in adults with locally advanced or metastatic non-small-cell lung cancer | DG9 | | |
| Intraoperative tests (RD‑100i OSNA system and Metasin test) for detecting sentinel lymph node metastases in breast cancer | DG8 | | |
| Varicose veins: diagnosis and management | CG168 | | |
| Falls in older people: assessing risk and prevention | CG161 | | |
| Physical activity: brief advice for adults in primary care | PH44 | | |
| Social anxiety disorder: recognition, assessment and treatment | CG159 | | |
| Antisocial personality disorder: prevention and management | CG77 | | |
| Hepatitis B and C testing: people at risk of infection | PH43 | | |
| Physical activity: walking and cycling | PH41 | | |
| Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M | DG6 | | |
| Social and emotional wellbeing: early years | PH40 | | |
| Neutropenic sepsis: prevention and management in people with cancer | CG151 | | |
| SonoVue (sulphur hexafluoride microbubbles) – contrast agent for contrast-enhanced ultrasound imaging of the liver | DG5 | | |
| Mega Soft Patient Return Electrode for use during monopolar electrosurgery | MTG11 | | |
| Sickle cell disease: managing acute painful episodes in hospital | CG143 | | |
| Service user experience in adult mental health: improving the experience of care for people using adult NHS mental health services | CG136 | | |
| Healthcare-associated infections: prevention and control | PH36 | | |
| The EOS 2D/3D imaging system | DG1 | | |
| Ambulight PDT for the treatment of non-melanoma skin cancer | MTG6 | | |
| The MIST Therapy system for the promotion of wound healing | MTG5 | | |
| Type 2 diabetes prevention: population and community-level interventions | PH35 | | |
| Coexisting severe mental illness (psychosis) and substance misuse: assessment and management in healthcare settings | CG120 | | |
| Food allergy in under 19s: assessment and diagnosis | CG116 | | |
| Sedation in under 19s: using sedation for diagnostic and therapeutic procedures | CG112 | | |
| Unintentional injuries: prevention strategies for under 15s | PH29 | | |
| Unintentional injuries in the home: interventions for under 15s | PH30 | | |
| Unintentional injuries on the road: interventions for under 15s | PH31 | | |
| Bedwetting in under 19s | CG111 | | |
| Pregnancy and complex social factors: a model for service provision for pregnant women with complex social factors | CG110 | | |
| Weight management before, during and after pregnancy | PH27 | | |
| Cardiovascular disease prevention | PH25 | | |
| Alcohol-use disorders: prevention | PH24 | | |
| Improving outcomes for people with skin tumours including melanoma | CSG8 | | |
| Donor milk banks: service operation | CG93 | | |
| Depression in adults with a chronic physical health problem: recognition and management | CG91 | | |
| Diarrhoea and vomiting caused by gastroenteritis in under 5s: diagnosis and management | CG84 | | |
| Rehabilitation after critical illness in adults | CG83 | | |
| Medicines adherence: involving patients in decisions about prescribed medicines and supporting adherence | CG76 | | |
| Borderline personality disorder: recognition and management | CG78 | | |
| Physical activity for children and young people | PH17 | | |
| Mental wellbeing in over 65s: occupational therapy and physical activity interventions | PH16 | | |
| Cardiovascular disease: identifying and supporting people most at risk of dying early | PH15 | | |
| Physical activity in the workplace | PH13 | | |
| Behaviour change: general approaches | PH6 | | |
| Acutely ill adults in hospital: recognising and responding to deterioration | CG50 | | |
| Drug misuse in over 16s: opioid detoxification | CG52 | | |
| Drug misuse in over 16s: psychosocial interventions | CG51 | | |
| Faecal incontinence in adults: management | CG49 | | |
| Improving outcomes for people with brain and other central nervous system tumours | CSG10 | | |
| Improving outcomes for people with sarcoma | CSG9 | | |
| Obsessive-compulsive disorder and body dysmorphic disorder: treatment | CG31 | | |
| Improving outcomes in children and young people with cancer | CSG7 | | |
| Improving outcomes in head and neck cancers | CSG6 | | |
| Dental checks: intervals between oral health reviews | CG19 | | |
| Improving supportive and palliative care for adults with cancer | CSG4 | | |
| Improving outcomes in urological cancers | CSG2 | | |
| Improving outcomes in breast cancer | CSG1 | | |